Atai plans to begin a Phase 2 study by the end of 2024 to evaluate VLS-01's safety, efficacy and durability in TRD patients. EMP-01 for Social Anxiety Disorder: EMP-01 is an oral R-MDMA formulation ...
Knowing that the NHL’s top player likely won’t be buying its most popular product anytime soon, the brand’s Canadian social media account took aim at McDavid with a hilarious chirp. While the usual ...
The data come as various levels of government attempt to tackle the issue of social disorder, primarily in downtowns in Canadian cities such as Calgary. Businesses have meanwhile spent a median of ...
Social anxiety disorder is marked by an intense fear of judgment, the strong and pervasive sense that most people are thinking poorly of you, and the equally intense urge to avoid most ...